Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors

Pediatric Blood and Cancer

Volumn 54, Issue 4, 2010, Pages 649-651

  Gajjar, Amar ^a,c,d,e   Pizer, Barry ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^c Division of Neuro Oncology

^d Neurobiology and Brain Tumor Program

^e Department of Oncology ^*

Author keywords

High dose chemotherapy; PNETs; Recurrence

Indexed keywords

BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; MELPHALAN; THIOTEPA;

AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; DISEASE FREE SURVIVAL; DRUG MEGADOSE; HUMAN; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MEDULLOBLASTOMA; NEOPLASM RECURRENCE, LOCAL; NEUROECTODERMAL TUMORS, PRIMITIVE;

EID: 77649093393     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22378     Document Type: Review

References (18)

1. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328:1725-1731.
2. Geyer JR, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Childrens Cancer Group. J Clin Oncol 1994;12:1607-1615.
3. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: A report from the Children's Cancer Group. J Clin Oncol 2005; 23:7621-7631.
4. Grill J, Sainte-Rose C, Jouvet A, et al. Treatment of medulloblastoma with postoperative chemotherapy alone: An SFOP prospective trial in young children. Lancet Oncol 2005;6:573-580.
5. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352:978-986.
6. Chi SN, Gardner SL, Levy AS, et al. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 2004;22:4881-4887.
7. Blaney S, Boyett J, Friedman H, et al. Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: A Pediatric Brain Tumor Consortium Study (PBTC-001). J Clin Oncol 2005;23:525-531.
8. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol 2006;7:813-820.
9. Oyharcabal-Bourden V, Kalifa C, Gentet JC, et al. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: A French Society of Pediatric Oncology Study. J Clin Oncol 2005;23:4726-4734.
10. Packer RJ, Gajjar A, Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006;24: 4202-4208.
11. 1) medulloblastoma. The SIOP/ UKCCSG PNET-3 study. J Clin Oncol 2003;21:1581-1591.
12. Gottardo NG, Gajjar A. Current therapy for medulloblastoma. Curr Treat Options Neurol 2006;8:319-334.
13. Finlay JL, Goldman SL, Wong MC, et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. J Clin Oncol 1996;14:2495-2503.
14. Dunkel IJ, Boyett JM, Yates A, et al. High-dose carboplatin, thiotepa and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. J Clin Oncol 1998;16: 222-228.
15. Gururangan S, Dunkel IJ, Goldman S, et al. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. J Clin Oncol 1998;16:2486-2493.
16. Ridola V, Grill J, Doz F, et al. High-dose chemotherapy with autologous stem cell rescue followed by posterior-fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy. Cancer 2007;110:156-163.
17. Gajjar A, Mulhern RK, Heideman RL, et al. Medulloblastoma in very young children: Outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol 1994;12:1212-1216.
18. Walter AW, Mulhern RK, Gajjar A, et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol 1999;17: 3720-3728.